FDA Inspection 951274 — Innovative Transfusion Medicine, Inc.

Innovative Transfusion Medicine, Inc. — FEI 3000207042

The FDA completed an inspection of Innovative Transfusion Medicine, Inc. on December 8, 2015 in Miami Lakes, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 8, 2015
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Miami Lakes, FL (United States)